Malignant Tumor Treatment Technologies

Malignant Tumor Treatment Technologies (MT3) is a biotechnology company focused on developing innovative medical devices and therapies for the treatment of solid tumors. The company's core technology utilizes advanced electroporation techniques to enhance the delivery of therapeutic agents directly into malignant tissues while modulating the tumor microenvironment. By combining localized physical energy with systemic or local immunotherapies, MT3 aims to improve treatment efficacy and reduce systemic toxicity for difficult-to-treat cancers. Their current research efforts are primarily directed toward indications such as pancreatic and head and neck cancers.